ES
Estrella Immunopharma, Inc.
ESLA · NASDAQ
$0.69 -0.29% (-$0.00)
1M -13.23%
Market Cap $29.5M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 548.74%
Asset turnover 0.00x
ROIC 131.75%
Debt
0 /100
High Current ratio 0.20x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
79 /100
Stable EPS volatility 11.03%
Profitable years 0
Beta 0.89x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ESLA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheng Liu
Employees
3
Headquarters
EmeryVille
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report